FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297081653> ?p ?o ?g. }

• W4297081653 endingPage "1309" @default.
• W4297081653 startingPage "1298" @default.
• W4297081653 abstract "Abstract The aim of this clinical trial was to assess the efficacy and safety of low‐dose triple combinations of amlodipine, telmisartan, and chlorthalidone in patients with essential hypertension. After a 2‐week placebo run‐in period, 176 patients were randomized to seven treatment groups (placebo, quarter‐dose combination, third‐dose combination, half‐dose combination, amlodipine 5 mg, amlodipine 10 mg, and telmisartan 80 mg) and administered the assigned study drug orally for 8 weeks. The primary efficacy endpoint was the change in the mean sitting systolic blood pressure (BP) (MSSBP) at Week 8. The MSSBP and mean sitting diastolic BP in the quarter‐dose and half‐dose groups were significantly lower compared to the placebo and amlodipine 5 mg groups, with similar BP‐lowering effects observed compared to the amlodipine 10 mg and telmisartan 80 mg groups. However, the third‐dose group showed significant BP improvement only compared to the placebo group. A similar pattern was observed for the control rate of hypertension and response rates. Additional analysis was conducted after correcting for gender and age effects, and, as a result, the third‐dose group showed similar results with regard to the BP‐lowering effect as the quarter‐dose and half‐dose groups. In terms of safety, no special adverse events and clinically significant results were noted, and all dose groups of the triple combination are considered safe for use in essential hypertension patients. The current findings indicated that low‐dose triple combination of amlodipine, telmisartan, and chlorthalidone over 8 weeks effectively improved the BP‐lowering effect in patients with essential hypertension without any safety concerns." @default.
• W4297081653 created "2022-09-26" @default.
• W4297081653 creator A5008317220 @default.
• W4297081653 creator A5010133256 @default.
• W4297081653 creator A5012651577 @default.
• W4297081653 creator A5016809969 @default.
• W4297081653 creator A5018800406 @default.
• W4297081653 creator A5024282773 @default.
• W4297081653 creator A5038699850 @default.
• W4297081653 creator A5041232617 @default.
• W4297081653 creator A5041586597 @default.
• W4297081653 creator A5056454145 @default.
• W4297081653 creator A5062026145 @default.
• W4297081653 creator A5066090425 @default.
• W4297081653 creator A5071432021 @default.
• W4297081653 creator A5072281476 @default.
• W4297081653 creator A5075770656 @default.
• W4297081653 creator A5080713811 @default.
• W4297081653 creator A5085895771 @default.
• W4297081653 date "2022-09-12" @default.
• W4297081653 modified "2023-09-25" @default.
• W4297081653 title "Efficacy and safety of low‐dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double‐blind, parallel, phase II trial" @default.
• W4297081653 cites W1980967898 @default.
• W4297081653 cites W2028608751 @default.
• W4297081653 cites W2046728370 @default.
• W4297081653 cites W2110880027 @default.
• W4297081653 cites W2129409540 @default.
• W4297081653 cites W2157677292 @default.
• W4297081653 cites W2160547085 @default.
• W4297081653 cites W2437822687 @default.
• W4297081653 cites W2726523818 @default.
• W4297081653 cites W2774395011 @default.
• W4297081653 cites W2887966018 @default.
• W4297081653 cites W2888926850 @default.
• W4297081653 cites W3021406499 @default.
• W4297081653 cites W3081340265 @default.
• W4297081653 cites W3114506540 @default.
• W4297081653 cites W3198606485 @default.
• W4297081653 cites W3209763659 @default.
• W4297081653 cites W4297081653 @default.
• W4297081653 cites W84856835 @default.
• W4297081653 doi "https://doi.org/10.1111/jch.14570" @default.
• W4297081653 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36094783" @default.
• W4297081653 hasPublicationYear "2022" @default.
• W4297081653 type Work @default.
• W4297081653 citedByCount "2" @default.
• W4297081653 countsByYear W42970816532022 @default.
• W4297081653 countsByYear W42970816532023 @default.
• W4297081653 crossrefType "journal-article" @default.
• W4297081653 hasAuthorship W4297081653A5008317220 @default.
• W4297081653 hasAuthorship W4297081653A5010133256 @default.
• W4297081653 hasAuthorship W4297081653A5012651577 @default.
• W4297081653 hasAuthorship W4297081653A5016809969 @default.
• W4297081653 hasAuthorship W4297081653A5018800406 @default.
• W4297081653 hasAuthorship W4297081653A5024282773 @default.
• W4297081653 hasAuthorship W4297081653A5038699850 @default.
• W4297081653 hasAuthorship W4297081653A5041232617 @default.
• W4297081653 hasAuthorship W4297081653A5041586597 @default.
• W4297081653 hasAuthorship W4297081653A5056454145 @default.
• W4297081653 hasAuthorship W4297081653A5062026145 @default.
• W4297081653 hasAuthorship W4297081653A5066090425 @default.
• W4297081653 hasAuthorship W4297081653A5071432021 @default.
• W4297081653 hasAuthorship W4297081653A5072281476 @default.
• W4297081653 hasAuthorship W4297081653A5075770656 @default.
• W4297081653 hasAuthorship W4297081653A5080713811 @default.
• W4297081653 hasAuthorship W4297081653A5085895771 @default.
• W4297081653 hasBestOaLocation W42970816531 @default.
• W4297081653 hasConcept C126322002 @default.
• W4297081653 hasConcept C126894567 @default.
• W4297081653 hasConcept C142724271 @default.
• W4297081653 hasConcept C168563851 @default.
• W4297081653 hasConcept C197934379 @default.
• W4297081653 hasConcept C204787440 @default.
• W4297081653 hasConcept C27081682 @default.
• W4297081653 hasConcept C2776623344 @default.
• W4297081653 hasConcept C2779646130 @default.
• W4297081653 hasConcept C2779716603 @default.
• W4297081653 hasConcept C2780427769 @default.
• W4297081653 hasConcept C71924100 @default.
• W4297081653 hasConcept C84393581 @default.
• W4297081653 hasConcept C98274493 @default.
• W4297081653 hasConceptScore W4297081653C126322002 @default.
• W4297081653 hasConceptScore W4297081653C126894567 @default.
• W4297081653 hasConceptScore W4297081653C142724271 @default.
• W4297081653 hasConceptScore W4297081653C168563851 @default.
• W4297081653 hasConceptScore W4297081653C197934379 @default.
• W4297081653 hasConceptScore W4297081653C204787440 @default.
• W4297081653 hasConceptScore W4297081653C27081682 @default.
• W4297081653 hasConceptScore W4297081653C2776623344 @default.
• W4297081653 hasConceptScore W4297081653C2779646130 @default.
• W4297081653 hasConceptScore W4297081653C2779716603 @default.
• W4297081653 hasConceptScore W4297081653C2780427769 @default.
• W4297081653 hasConceptScore W4297081653C71924100 @default.
• W4297081653 hasConceptScore W4297081653C84393581 @default.
• W4297081653 hasConceptScore W4297081653C98274493 @default.
• W4297081653 hasIssue "10" @default.
• W4297081653 hasLocation W42970816531 @default.
• W4297081653 hasLocation W42970816532 @default.

• next